Skip to main content
. 2020 Feb 8;116(4):817–828. doi: 10.1093/cvr/cvaa009

Figure 3.

Figure 3

Schematic overview of the mechanisms involved in the systemic endothelial dysfunction that is present in patients with rheumatic inflammatory diseases, in relation to the occurrence of cardiovascular events. IFN, interferon; IL-2, interleukin-2; PA, psoriatic arthritis; RA, rheumatic arthritis; RFs, risk factors; SLE, systemic lupus erythematosus; SS, systemic sclerosis; TNF, tumour necrosis factor.